Amicus Therapeutics, Inc.
FOLD
$14.38
$0.010.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.11M | -14.06M | -38.10M | -29.37M | -56.11M |
| Total Depreciation and Amortization | 7.46M | 7.60M | 7.90M | 8.23M | 8.55M |
| Total Amortization of Deferred Charges | 2.57M | 2.49M | 2.41M | 2.34M | 2.26M |
| Total Other Non-Cash Items | 89.86M | 93.61M | 92.89M | 92.98M | 110.35M |
| Change in Net Operating Assets | -39.63M | -76.67M | -110.76M | -70.62M | -98.94M |
| Cash from Operations | 33.15M | 12.98M | -45.66M | 3.56M | -33.89M |
| Capital Expenditure | -3.30M | -3.29M | -3.26M | -1.95M | -3.55M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.14M | -57.05M | -21.50M | -39.00M | 2.99M |
| Cash from Investing | -46.43M | -60.33M | -24.76M | -40.96M | -560.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -272.00K | -83.00K | -42.00K | -70.00K | -97.00K |
| Issuance of Common Stock | 19.21M | 2.45M | 23.07M | 23.89M | 27.24M |
| Repurchase of Common Stock | -18.32M | -14.69M | -15.84M | -17.09M | -22.03M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 610.00K | -12.32M | 7.19M | 6.73M | 5.12M |
| Foreign Exchange rate Adjustments | 13.28M | 16.71M | 12.89M | 2.60M | -4.03M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 600.00K | -42.96M | -50.34M | -28.06M | -33.36M |